Key facts
- This page summarizes Knight Therapeutics Inc.'s Form 3 filing for 60 DEGREES PHARMACEUTICALS, INC. (SXTP).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 29 Jul 2026, 16:06.
Knight Therapeutics Inc. - 22 Jul 2026 Form 3 Insider Report for 60 DEGREES PHARMACEUTICALS, INC. (SXTP)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- SXTP
- Reported as of
- 22 Jul 2026
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 29 Jul 2026, 16:06:24 UTC
- Prior SEC filing
- 13 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Samira Sakhia President and Chief Executive Officer
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Knight Therapeutics Inc. filed Form 3 for 60 DEGREES PHARMACEUTICALS, INC. (SXTP) on 29 Jul 2026.
Change
- Previous filing in this sequence was filed on 13 Jun 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0001756235
Primary reporting owner
Knight Therapeutics Inc.
- Relationship
- 10%+ Owner
- Address
- 600 - 100 BOUL. ALEXIS NIHON, MONTREAL, QUEBEC, CANADA
- Signature
- /s/ Samira Sakhia President and Chief Executive Officer
- Signature date
- 28 Jul 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SXTP
holding
Common Stock, $0.0001 par value per share
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 658,629
- Date
- 22 Jul 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.